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Trypanosomes encode a family of proteins known as Major Surface Metalloproteases (MSPs). We have identiﬁed six putative MSPs
encoded within the partially sequenced T. congolense genome. Phylogenic analysis indicates that T. congolense MSPs belong to
ﬁve subfamilies that are conserved among African trypanosome species. Molecular modeling, based on the known structure of
Leishmania Major GP63, reveals subfamily-speciﬁc structural variations around the putative active site despite conservation of
overall structure, suggesting that each MSP subfamily has evolved to recognize distinct substrates. We have cloned and puriﬁed
a protein encoding the amino-terminal domain of the T. congolense homologue TcoMSP-D (most closely related to Leishmania
GP63). We detect TcoMSP-D in the serum of T. congolense-infected mice. Mice immunized with the amino-terminal domain of
TcoMSP-D generate a persisting IgG1 antibody response. Surprisingly, a low-dose challenge of immunized mice with T. congolense
signiﬁcantly increases susceptibility to infection, indicating that immunity to TcoMSP-D is a factor aﬀecting virulence.
1.Introduction
African trypanosomes cause devastating disease within
humans and livestock. Trypanosoma brucei gambiense and
T. b. rhodesiense cause sleeping sickness in humans. African
trypanosomiasis in domestic animals is caused by infections
with T. congolense, T. vivax,o rT. b. brucei,o fw h i c hT.
congolense is the most important pathogen for livestock
[1]. Antiparasite drugs are available but far from ideal
[2]. Vaccination has not been eﬀective as the periodic
switching among genes encoding for the immunodominant
variable surface glycoprotein (VSG) coat of the parasite
precludes use of this surface molecule as a candidate
[3–6].
Given the variability in the VSG coat we are examining
the feasibility of generating pre-existing immunity to invari-
ant surface proteins or secreted virulence factors as a means
of controlling trypanosome infection. Our model organism
is T. congolense, a causative agent of the chronic wasting
disease of livestock, Nagana. T. congolense remains in the
blood stream throughout the infection. Thus generation of
ap r o t e c t i v ei m m u n er e s p o n s et os u r f a c e - e x p o s e do rs e c r e t e d
virulence factors of the blood stream form should have the
potential to prevent or limit disease.
Among the African trypanosomes, T. brucei has previ-
ously been demonstrated to encode Major Surface Proteases
(MSPs) with homology to MSPs of Leishmania [7]. In
addition, the blood stream form T. brucei has been shown
to be killed in vitro by a peptidomimetic inhibitor that
speciﬁcally blocks L. major MSP activity [8]. Together, these
observations suggest that at least one MSP homologue is
expressed and essential for survival in the blood stream
form of T. brucei. Based on this, and the ﬁndings that in
Leishmania this family of proteins is important for virulence
and is surface-exposed [9], we were encouraged to pursue
whether T. congolense also encoded MSP homologues, and
whether immunity to a member(s) of this family could
attenuate T. congolense infection.2 Journal of Biomedicine and Biotechnology
To date, there have been no reports of MSP homo-
logues found in T. congolense. Fortunately, the African try-
panosome sequencing project undertaken by the Wellcome
Trust Sanger Institute (http://www.sanger.ac.uk/)h a sn o w
generated a signiﬁcant amount of sequence information
for T. congolense, though it has yet to be annotated. We
performed searches of the available T. congolense sequence
for predicted homologues to known MSPs of T. brucei and
Leishmania sp. We found six potential MSP encoding ORFs.
Two of the potential MSPs are >95% identical whereas
the remaining four are <40% identical to each other,
suggesting that we had tentatively identiﬁed ﬁve subfam-
ilies of MSPs within T. congolense. A phylogenic analysis
between the T. congolense MSPs and homologues found
in other African and new world trypanosomes revealed
that they indeed are representatives of ﬁve subfamilies that
are shared among African trypanosomes. We subsequently
cloned and expressed a region encoding the amino-terminal
domain of the putative MSP ORF from T. congolense
whose subfamily was found to group the closest with MSPs
from Leishmania sp. Antisera against this domain revealed
one major band in a Western blot of lysates of blood
stream forms of T. congolense, strongly suggesting that this
subfamily is expressed during infection. We describe the
immunizationwiththispuriﬁedpartialproteinanditseﬀects
on a subcutaneous infection of mice with a low dose of
T. congolense.
2.MaterialsandMethods
2.1. Parasites. T. congolense, Trans Mara strain, variant
antigenic types TC13 and TC14 were used in this study.
The origin of the parasite strain [10] and clone TC13 [11]
has been described previously. T. congolense clone TC14
was obtained from a C57BL/6 mouse infected with 103 T.
congolense clone TC13. It was cloned from a blood sample
collected 14 days after the infection. The variant surface
glycoprotein of clone TC14 is diﬀerent from that of clone
TC13.
2.2. Sequence Analysis and Molecular Modeling. T. con-
golense DNA sequences encoding potential MSP homo-
logues were identiﬁed using TBLASTN via the Trypanosoma
Blast Server web page (http://www.sanger.ac.uk/cgi-bin/
blast/submitblast/t brucei/), using the published amino
acid sequences for T. brucei MSP-A, MSP-B, and MSP-
C[ 7]. Potential open reading frames were identiﬁed
using ORF Finder on the NCBI server (http://www.ncbi
.nlm.nih.gov/projects/gorf/)a n dM S Pf a m i l yh o m o l o gyc o n -
ﬁrmed by independent BLAST analysis of each identiﬁed
ORF against the NCBI database. ORFs showing homology
to annotated MSPs from the NCBI database were collected.
The closest homologues to these T. congolense putative MSPs
in other individual Trypanosome species were identiﬁed
using TBLASTN via the Trypanosoma Blast server for
T. b. gambiense and T. vivax and via the NCBI Blast
Server (http://blast.ncbi.nlm.nih.gov/Blast.cgi)f o rT. brucei
TREU927, T.b. rhodesiense,a n dT. cruzi, as were homologues
in Leishmania (taxid:5658). Full amino acid sequences for
each protein analyzed are provided in the Supplementary
Material available online at doi: 10.1155/2010/418157. Pro-
tein sequence alignments were generated and prepared for
presentation using ClustalX ver 2.0.7 [12]. Phylogenic trees
were generated by ClustalX using the bootstrapped N-J
method with 1000 iterations. The unrelated E. coli protease
HﬂB was included as an outgroup for alignment. Trees
were prepared for presentation using PhyloDraw ver 0.8
as radial trees with terminal leaf extension for clarity of
labeling, and Njplot ver 2.3 for display of bootstrap values
(Supplementary Figure 1S). Three-dimensional structures
for the predicted amino acid sequences of the putative
MSPs were generated via the web-based server 3D-JIGSAW
(http://bmm.cancerresearchuk.org/∼3djigsaw/)[ 13], using
the provided default settings. Figures were generated from
the resulting structural ﬁles using PyMol1.1 [14]. Predicted
amino acid sequences for the MSPs were submitted to
PredGPI (http:// gpcr2.biocomp.unibo.it/predgpi/pred.htm)
[15] to predict the presence of a potential GPI anchor site
and to Signal 3.0 Server (http://www.cbs.dtu.dk/services/
SignalP/)[ 16] to predict the presence of a signal peptide
indicative of secretion.
2.3. Cloning, Expression, and Puriﬁcation of the Puta-
tive TcoMSP-D. The DNA sequence encoding the
amino-terminal domain of the MSP homologue from
clone TC13 (predicted residues 14–248), which we
named TcoMSP-D (see below), was ampliﬁed via
PCR from T. congolense chromosomal DNA. The
primers used for PCR were as follows: amino end,
5  CTGGGTACCGCAACAGTTTTGCTGCTGAC; carboxyl
end, 5  GTGCTCGAGTTAGGCCACATGTTCACTAAGG.
Restriction enzyme recognition sites for KpnI (amino end
primer) and XhoI (carboxyl end primer) used for directional
cloning are underlined. The resulting PCR product was
digested with KpnI and XhoI and ligated into similarly
digested pET30a expression vector (Novagen). The protein
construct is expressed under the control of the T7 promoter
and contains 39 additional residues (MHHHHHHSS-
GLVPRGSGMKETAAAKFERQHMDSPDLGTA) including a
six residue histidine tag at the N-terminal. The plasmid was
transformed into competent cells of the E. coli BL21(DE3)
strain for protein expression. The amino-terminal domain
of TcoMSP-C was similarly prepared but will be described
i nf u l le l s e w h e r e( H .B u l l ,G .W e i ,V .M a r c o u x ,H .T a b e l
unpublished).
Protein expression was induced by adding 0.4mM iso-
propyl 1-thio-β-D-galactopyranoside when the cells reached
anOD600 of0.5–0.7absorbanceunits,followedbya2-3-hour
incubation period at 37◦C. The cells were then harvested by
centrifugation, and the resulting pellet suspended in buﬀer
A prior to lyses by French press. The resulting lysate was
centrifuged at 15,000g for 20 minutes and supernatant and
pellet assayed by SDS PAGE for the presence of the expressed
protein. The protein was found to remain with the cell debris
pellet, likely as an inclusion body. The pellet was dissolved in
6M guanidine hydrochloride and the his-tagged protein wasJournal of Biomedicine and Biotechnology 3
subsequently puriﬁed using nickel aﬃnity chromatography
in the presence of 6M guanidine hydrochloride throughout.
The elution buﬀer was exchanged through extensive dialysis
withPBSat pH 7.4. The protein yield was2mgmL−1 withan
estimated 95% purity as determined by SDS-polyacrylamide
gel electrophoresis and staining with coomassie brilliant
blue.
2.4. Immunization and Antibody Production. Each of two
female eight-week-old New Zealand White rabbits was
injected subcutaneously at multiple sites with 1mg puri-
ﬁed amino-terminal domain of TcoMSP-D emulsiﬁed in
TiterMax Gold adjuvant (Sigma chemicals). Rabbits were
boosted at four weeks with identically prepared inoculums.
Blood was collected at eight weeks, and separated serum was
stored at –20◦C without further puriﬁcation. Groups of 5
six- to eight-week-old female BALB/c AnNCrlBR (BALB/c)
mice were injected subcutaneously (s.c.) with TiterMax
alone (Control), 5μg, or 50μg of N-terminal fragment of
TcoMSP-DinTiterMaxat4diﬀerentsites(25μL/site).Blood
was collected at two, four, and six weeks and checked for
serum antibody titers to puriﬁed amino-terminal domain
of TcoMSP-D by ELISA. Rabbits and mice were kept in
polycarbonate cages on sawdust and allowed free access to
food and water throughout the experiments, according to
the recommendation of the Canadian Council of Animal
Care. All animal experiments were conducted in accordance
with the standards of the University Committee on Animal
Care and Supply of the University of Saskatchewan (Protocol
numbers 20070043 and 19920139).
2.5. Western Analysis. Puriﬁed blood-stream T. congolense
TC13 [17] was solubilized in 2X-SDS loading buﬀer (95◦C
for two minutes) and the equivalent of 5 million parasites
per lane were separated by SDS PAGE in a 12% slab gel.
Separated proteins were transferred to a Hybond-P (GE
Healthcare) nylon membrane using a Minitrans-Blot cell
(Bio-Rad) at 100V for 1 hour. After transfer, membranes
were blocked for one hour with TBS/0.2% Tween-20/2.5%
skim milk, followed by one-hour incubation in the presence
of immune sera (1/500 dilution for rabbit anti-amino-
terminal domain of TcoMSP-D). Bound antibody was
detected by incubation with HRP-conjugated secondary goat
antirabbit antibody at 1/500 in TBS/0.2%Tween-20/2.5%
skim milk. For detection of TcoMSP-D in serum of infected
BALB/c mice the equivalent of 0.5μL of cell-free serum was
loaded per lane of a 12% SDS PAGE gel and detected as
above.
2.6. ELISA for TcoMSP-D Amino-Terminal Domain-Speciﬁc
Antibodies. Immulon 4HBX (Thermo) ELISA plates were
coated overnight at 4◦C with puriﬁed TcoMSP-D amino-
terminal domain (1μg/well in 100μL of coating buﬀer). The
plates were washed twice with PBS/Twen-20 (PBST) and
blocked with 5% skim milk in PBST, 200μL/well, for 2 hours
at 37◦C. After 4 washes, twofold serial diluted normal or
test mouse sera were carried out in antibody diluents (PBST
containing 2.5% skim milk), 100μL/well. The plates were
incubated for 2 hours at 37◦C and then washed four times.
HRP-conjugated goat antimouse IgG1 or IgG2a (Southern
Biotechnology Associates) in antibody diluents was added
and incubated for one hour at 37◦C. After six washes with
PBST, color development was achieved by adding 100μLo f
TMB peroxidase substrate (KPL) and incubating the plates
a tr o o mt e m p e r a t u r ei nt h ed a r kf o r1 0t o2 0m i n u t e s .
The reaction was stopped by adding 50μLo f1 MH 2SO4
to each well. OD450 was read in a microtiter plate ELISA
reader.
2.7. Mouse Infection Challenge. Mice immunized as
described above were infected with 2 × 103 T. congolense
clone TC14 s.c. in a hind footpad (i.f.p.). A drop of blood
was taken from the tail vein of each infected mouse. The
parasitemia was estimated by counting the number of
parasites present in at least 10 ﬁelds at X400 magniﬁcation
by phase-contrast microscopy. A count of 256 parasites per
ﬁeld is equivalent to ∼109 parasites/mL [18]. The survival
time was deﬁned as the number of days post infection during
which the infected mice remained alive. Moribund mice
were euthanized.
2.8. Statistical Analysis. Data are represented as means ± SE.
Signiﬁcance of diﬀerences was determined by ANOVA using
StatView SE1988 Software (Abacus Concepts) or a log-rank
test for curve comparison using a GraphPad Prism computer
program (BD Biosciences).
3. Results
3.1.IdentifyingMSPHomologuesinT.congolense. To identify
potential MSP homologues encoded by T. congolense,w e
performed a TBLASTN analysis against the partially com-
pleted and nonannotated T. congolense genome sequencing
database currently being compiled by the Wellcome Trust
Sanger Institute (http://www.sanger.ac.uk/). We searched for
proteins with signiﬁcant homology to previously character-
ize MSP-A, MSP-B, and MSP-C from T. brucei [7]a sw e l la s
to the highly conserved nine amino acid motif thought to be
important in Zn2+ binding at the catalytic active site. Both
approaches yielded similar results. Our searches revealed a
number of DNA sequence contigs that potentially encode
MSP homologues. Each contig was examined for potential
openreadingframes(ORFs).Thepredictedproteinsequence
from each detected ORF was independently subjected to a
BLAST homology search of the NCBI public databases to
reveal those with high homology to previously identiﬁed
members of the MSP family in related species. Using this
approach we have identiﬁed six full length ORFs encoding
putative MSP homologues in T. congolense. Four of the six
full-length homologues are notably diverse in their predicted
amino acid sequences (Figure 1). On the basis of phylogenic
analysisdescribedindetailbelowwehavenamedtheputative
MSPs TcoMSP-A, TcoMSP-B1, TcoMSP-B2, TcoMSP-C,
TcoMSP-D, and TcoMSP-E. Interestingly, the two members
showing high homology to each other are located adjacent
to each other on the same DNA contig, perhaps suggesting4 Journal of Biomedicine and Biotechnology
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Figure 1: Multiple sequence alignment of T. congolense MSP homologues. The predicted amino acid sequences for each T. congolense MSP
homologue were aligned to each other using the ClustalW alignment tool. Output was directly generated using ClustalX for Windows. The
dashed red box indicates a conserved motif shown to be essential for Zn2+ binding in related proteins.
a tandem array with multiple members of this particular
subfamily. Notably, others have found a family of MSP-B
homologues to be arranged as a tandem array in T. brucei
[19]. The remaining four genes identiﬁed are not ﬂanked by
MSP homologues within their respective assembled contigs.
The alignment shown in Figure 1 reveals that there is
considerable variation among the proteins, with extensive
variation at both the amino and carboxyl ends. Remarkably
however, there are 18 conserved cysteine residues inter-
spersed throughout the proteins as well as a lesser number
of conserved glycine and proline residues. This ﬁnding, in
conjunction with the conservation of the putative active
site, strongly suggests that this family of diverse proteins
has retained a common set of folds, and thus an overall
conservation of tertiary structure.
Given the potential retention of tertiary structure,
we attempted molecular modeling of the putative MSPs
using the 3DjigSaw protein modeling server (http://bmm
.cancerresearchuk.org/∼3djigsaw/). The program was able
to generate predicted structure ﬁles for each MSP. The
ﬁrst column of Figure 2 presents a cartoon model for each
predicted structure as well as the solved structure for L.
major MSP GP63 (1LML.pdb) [20]. Despite some individual
loop deviations the overall three domain core structure is
remarkably well retained through all six structures. The
overlays between each T. congolense homologue and 1LML
structure in the center column reveal that the key folds
around the putative active site (centered around the zinc
ion shown in grey) are very highly conserved. This supports
the interpretation that these proteins are homologues of
L. major MSP GP63, which is a virulence factor [9].
However, the third column reveals key topological and
surfacechargediﬀerencesbetweenGP63andbetweeneachof
the predicted T. congolense MSPs around the putative active
site. If these proteins retain protease activity, it is evident
that they are very likely to have distinctly diﬀerent substrate
speciﬁcities.
3.2. Identifying Subfamilies among MSP Homologues. Given
the observed diversity between the putative MSPs, we
were interested to determine if they were representative
members of conserved subfamilies in African trypanosomes,
or if they were speciﬁc to T. congolense. To address this
question, we queried the databases for predicted proteins
showing the highest homology to each T. congolense MSP
independently. To ensure suﬃcient depth to our analysis,
we retained the predicted amino acid sequences for the
three most homologous to each T. congolense MSP from
each of T. brucei TREU 927, T. brucei rhodesience, T. brucei
gambiense,andT. vivax aswellasfromtheCentralandSouthJournal of Biomedicine and Biotechnology 5
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Figure 2: Predicted structures of T. congolense MSP homologues. Predicted amino acid sequences for each homologue were submitted
for molecular modeling to the 3D-JigSaw comparative modeling web server (http://bmm.cancerresearchuk.org/∼3djigsaw/). The solved
LeishmaniaGP63crystalstructure1LML.pdbwaschosenbytheprogram(independentlyoftheuser)asthebestﬁtasamodelingtemplatefor
each protein. The resulting generated pbd structure ﬁles were visualized using PyMOL Molecular Graphics System Version 1.1r1. Individual
structures on the left side of the ﬁgure are as follows: (a) Leishmania GP63 (1LML.pdb), (b) TcoMSP-D, (c) TcoMSP-B1, (d) TcoMSP-A,
(e) TcoMSP-C, and (f) TcoMSP-E. The center column depicts an overlay of that structure with the structure of Leishmania GP63. The third
columndepictsasurfacerepresentationofeachpredictedstructureandLeishmaniaGP63onthefacecontainingtheputativeactivesite.Red-
orange regions denote oxygen atoms, blue regions denote nitrogen atoms, green denotes carbon and hydrogen atoms, and yellow denotes
sulfur atoms. The light grey sphere indicates the position of the Zn2+ ion in the solved Leishmania GP63 structure. It has been modeled into
the predicted structures as an aid to orientation.
American trypanosome species T. cruzi. We also performed
queries against the related Leishmania taxid. In cases where
individual T. congolense MSPs retrieved the identical protein
from a queried species, duplicates were removed. The amino
acid sequences described for T. brucei MSP-A, MSP-B, and
MSP-C were also included for comparison [7]. Figure 3
shows the radial phylogenic tree generated from comparison
of this resulting group of 55 predicted protein sequences.6 Journal of Biomedicine and Biotechnology
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Figure 3: Clustal-W generated dendogram comparing T. congolense putative MSPs with predicted homologues from T. brucei TREU927, T.
brucei gambiense, T. vivax, T. brucei rhodesiense, T. cruzi,a n dLeishmania sp. (taxid 5658). Predicted protein sequences were obtained in a
TBLASTN search against the translated genome database for each species indicated. The top three homologues were obtained for each T.
congolense putative MSP independently for each species indicated. Redundant retrievals were eliminated. Protein sequence alignments were
generated and prepared for presentation using ClustalX ver 2.0.7 [12]. Phylogenic trees were generated by ClustalX using the bootstrapped
N-J method with 1000 iterations. The unrelated E. coli protease HﬂB was included as an outgroup for alignment. Trees were prepared for
presentation using PhyloDraw ver 0.8 as radial trees. Note that the terminal arms have been extended for clarity of presentation and labeling
and therefore should not be considered in interpreting phylogenetic distance. T. congolense putative MSP proteins are indicated in bold
lettering. The T. brucei homologues previously characterized by LaCount et al. [7] are indicated for comparison. Nodes populated solely
from individual proteins from T. cruzi and Leishmania sp. are indicated by blue and red dashed circles, respectively. The individual putative
proteins represented by numbers in the tree are listed by number in Table 1. Full amino acid sequences for the proteins represented here are
available in the supplementary information as is a phylogenetic tree with bootstrap values and genetic distance indicated.
A number of interesting features are revealed by the
analysis. It is evident that indeed the six T. congolense MSPs
we have identiﬁed do fall into ﬁve discrete subfamilies. The
previouslydescribedT. brucei MSP-A,-B,and-Cfallintodis-
crete subfamilies and colocalize with TcoMSP-A, TcoMSP-
B1 and 2, and TcoMSP-C, respectively. Notably, TcoMSP-D
and TcoMSP-E each map to individual subfamilies that are
clearly distinct from those containing T. brucei MSP-A, -B,
and -C. This ﬁnding indicates that the African trypanosomes
share, at a minimum, ﬁve distinct subfamilies of MSPs, each
with closer homologues in related species than within their
o w ns p e c i e s .T h i si se x p e c t e df o rp r o t e i n st h a te v o l v e da n d
were selected in a common ancestor prior to speciation. This
also very likely implies subfamily speciﬁc functions/targets.
In an attempt to further classify the MSPs examined in
Figure 3, we submitted each of the proteins to predictions of
secretion signals (signal peptides) and GPI anchors. Table 1
lists each of the MSP proteins analyzed and indicates the
presence or absence of predicted signal peptides and GPI
anchor signals. The homologues examined fall into three
categories. Most (32 of the 55) are predicted to have a signal
peptide and a moderate or high probability of having a GPI
anchor. 19 are predicted to have a signal peptide and not
have a GPI anchor, suggesting that they are either actively
secreted, or anchored by another mechanism. Interestingly,
the remaining four homologues are not predicted to encode
either a signal peptide or a GPI anchor. If the motif
predictions reﬂect biological function, this indicates that thisJournal of Biomedicine and Biotechnology 7
subset of “Major Surface Proteases” may actually function
within the cytoplasm.
Predictions of localization for each of the T. congolense
MSPs can be made based on these motif patterns. TcoMSP-
D and neighboring proteins 3–7 have strong signal peptide
motifs and are not predicted to be GPI anchored. This
suggests that these proteins are actively secreted. Interest-
ingly, TcoMSP-C and its two closest predicted neighbors,
including the previously described TbMSP-C protein, are
alsopredictedtobeactivelysecreted.Conversely,TcoMSP-B-
1 and TcoMSP-B-2 and their MSP-B grouping homologues
are predicted to be exported and surface linked via a
GPI anchor. This prediction is in agreement with the
known function of TbMSP-B in life-cycle speciﬁc cleavage
of VSG from procyclic T. brucei [19]. It is very probable
that each member of this subfamily provides the same
function in each of the species represented. Of note, the T.
cruzi speciﬁc subgrouping of MSPs (proteins 25–31) also
universally encodes both signal peptides and GPI anchors.
ThiscommonalitywiththeTbMSP-Bsubfamilyissurprising
given that T. cruzi does not express VSG but rather produces
avariablemucincoat[21].Itispossiblethatthissubgroupof
T. cruzi MSPs plays an analogous role to TbMSP-B in the T.
cruzi life cycle, perhaps in shedding bloodstream-expressed
mucins. Similarly to the MSP-B subfamily, TcoMSP-A and
the grouping homologues from 42–50 also are predicted to
beexportedandsurfacelinkedviaaGPIanchor.Theroleand
targets of the MSP-A homologues have yet to be elucidated.
Unexpectedly, TcoMSP-E, and three out of four of its closest
homologues appear to lack both a leading transport signal
sequence and a GPI anchor motif indicating that they are
retained within the cytoplasm.
The Leishmania MSPs are all predicted to encode a signal
sequence but are mixed with regard to encoding predicted
GPI anchors. It is possible that some MSP members failed
to be recognized as having GPI anchors when in fact they
do, as others have found that some variants of Leishmania
MSP contain a variant GPI anchor signal [22]. Alternatively,
it is likely that some subsets of Leishmania MSPs are actively
secreted [23].
3.3. Cloning, Expression, and Puriﬁcation of Amino-Terminal
Domain of TcoMSP-D and Generation of Speciﬁc Antisera.
GiventheconservationoftheMSP-Dsubfamily,evenamong
the new world trypanosome T. cruzi, the known role of
LeishmaniaMSPsasvirulencefactors,andthepossibilitythat
TcoMSP-D may be secreted, we elected to further examine
TcoMSP-D as a potential target for attempted attenuation of
T. congolense infection.Indeed,thethreeMSP-Dhomologues
encodedbyT. congolense,T.bruceiTREU97,andT.gambiense
display a remarkably high level of identity (Figure 4). It is
very probable that these homologues target the identical
substrate in vivo. It is therefore likely that conditions or
treatments that are found to disrupt TcoMSP-D function
will also prove eﬀective against homologues in these related
species.
The amino-terminal domain from the ORF predicted
to encode TcoMSP-D was ampliﬁed by PCR and cloned
into the pET30a expression vector such that the expressed
protein would encode a poly-histidine (6-his) tag on the
amino end. The recombinant protein was puriﬁed following
induction from the expression vector via nickel aﬃnity
chromatography. Puriﬁed protein was used to inoculate
rabbits for polyclonal antibody production using a standard
immunization protocol. Rabbit antiserum was used as the
primary antibody for Western analysis of whole cell lysates
of blood stream forms of T. congolense separated by SDS
PAGE. Figure 5(b) reveals that the rabbit antiserum raised
against the puriﬁed TcoMSP-D amino-terminal domain
reacts with a protein with an apparent molecular weight of
about 40,000 daltons, which is considerably less than the
predicted molecular weight of 74,538 daltons for the full
length nascent form. Not visible on the scanned image but
visible to the naked eye are two faint larger molecular weight
bands of about 50,000 and 70,000 daltons. The relative
intensities of the observed bands are consistent both with
rapid and signiﬁcant posttranslational processing and with
degradationofthefulllengthprotein,neitherofwhichcanbe
conclusively proven from these data. We have independently
raised antiserum against the amino-terminal domain of
TcoMSP-C and ﬁnd that this serum detects a single protein
of approximately 120,000 daltons in lysates of blood-form
T. congolense (Bull, Wei, and Tabel, unpublished) suggesting
that there is little cross-reaction between expressed MSPs in
T. congolense (consistent with the low level of identity among
the putative MSP members (Figure 1)), and that more than
one subfamily is expressed in the blood stream form.
In an attempt to resolve the localization of TcoMSP-
Dw et r i e dt ov i s u a l i z eT c o M S P - Do nt h es u r f a c eo fﬁ x e d
bloodstreamformsoftheparasitewiththeuseofﬂuorescent
antibodies. The attempts by both direct microscopic exam-
ination and by FACS were unsuccessful. However, we did
detect TcoMSP-D in the serum of BALB/c mice following
intraperitoneal infection with 103 T. congolense, clone TC13.
No antigen was found in normal serum or serum collected
at three days postinfection (DPI) when the parasitemia was
less than 105 parasites per mL of blood. TcoMSP-D was
detected as a strong double band in serum at six DPI
(Figure 5(a)) when the parasitemia was 5 × 108 parasites
per mL. The TcoMSP-D detected in the serum of infected
mice had apparent molecular weights of about 40,000 and
43,000 daltons. While this result is in agreement with the
prediction that TcoMSP-D is secreted and further processed
and not surface-bound, we cannot rule out the possibility
that the observed protein is simply a degradation product
released from in vivo disrupted trypanosomes, or during
serum preparation. The relative abundance of the detected
protein band(s) in the 0.2μL serum sample (equivalent to
1 × 105 parasites) versus the obviously reduced amount seen
in 5×106 lysed puriﬁed blood-stream parasites suggests that
during the course of infection TcoMSP-D accumulates in
the blood to a level in excess of 50-fold greater than can be
accounted for by intact parasites. This indicates either that
TcoMSP-D is being actively secreted and is stable or that in
vivo destruction of the parasites by day six is very prominent
and released TcoMSP-D accumulates. Future studies will
be required to determine whether the detected form of the
protein has any function.8 Journal of Biomedicine and Biotechnology
Table 1: Major surface protease homologues.
Number Species Identiﬁer∗ Probability of a signal
peptide Probability of a GPI anchor
1 T. cruzi XM 808234 High (29-30) moderate
2 T. cruzi XM 806897 Not probable not probable
3 T. vivax 1037d01.p1k High (36-37) not probable
4 T. congolense TcoMSP-D High (23-24) not probable
5 T.b. gambiense 11 v2.orf-3 High (23-24 not probable
6 T. brucei TREU927 XM 823726 High (23-24) not probable
7 L. brazilliensis XM 001562766 High (30-31) not probable
8 L. guyanensis LEIGP63X High (41-42) High
9 L. mexicana X64394 High (41-42) not probable
10 L. donovani AJ495007 High (41-42) not probable
11 L. major XM 001681325 High (41-42) High
12 L. major XM 001681324 High (41-42) High
13 L. major XM 001684283 High (24-25) High
14 L. infantum XM 001470056 High (24-25) High
15 T. cruzi XM 802134 High (28-29) not probable
16 T. cruzi XM 807916 High (30-31) not probable
17 T. cruzi XM 801120 High (29-30) not probable
18 T. cruzi XM 799438 High (29-30) not probable
19 T. vivax 942f04.q1k High (30-31) low
20 T. vivax 1924b07.q1k High (36-37) High
21 T. vivax 1240d01.p1k High (36-37) High
22 T. congolense TcoMSP-C High (30-31) not probable
23 T.b. gambiense 10 v2 High (24-25) not probable
24 T.b TREU927 TbMSP-C=XM 817402 High (24-25) not probable
25 T. cruzi XM 799266 High (27-28) High
26 T. cruzi XM 802023 High (59-60) moderate
27 T. cruzi XM 798784 High (59-60) moderate
28 T. cruzi XM 815532 High (22-23) High
29 T. cruzi XM 815930 Poor (24-25) moderate
30 T. cruzi XM 812094 High (20-21) High
31 T. cruzi XM 798806 High (22-23) High
32 T. congolense TcoMSP-B1 High (21-22) High
33 T. congolense TcoMSP-B2 High (21-22) High
34 T. brucei TREU927 XM 841902 High (58-59) High
35 T.b. gambiense 08 v2 High (58-59) High
36 T. brucei TREU927 XM 841905 High (64-65) moderate
37 T.brucei TREU927 TbMSP-B=XM 841904 High (64-65) moderate
38 T. vivax 1393e12.p1k High (20-21) not probable
39 T. vivax 797h07.q1k High (22-23) not probable
40 T. vivax 899g05.p1k High (19-20) not probable
41 T. congolense TcoMSP-A High (27-28) moderate
42 T. brucei TREU927 XM 823758 High (26-27) High
43 T.b. gambiense 1167d01.p1k High (26-27) High
44 T.b. rhodesiense MSP-A2 High (26-27) High
45 T. brucei TREU927 XM 823757 High (26-27) High
46 T. b. gambiense 11 v2-orf2 High (26-27) High
47 T.b. gambiense 2537b02.p1k High (26-27) High
48 T. brucei TREU927 XM 823755 High (26-27) HighJournal of Biomedicine and Biotechnology 9
Table 1: Continued.
Number Species Identiﬁer∗ Probability of a signal
peptide Probability of a GPI anchor
49 T.b. rhodesiense MSP-A1 High (26-27) High
50 T.b. rhodesiense TbMSP-A=U86345 High (26-27) High
51 T. vivax 1124g05.p1k High (28-29) low
52 T. vivax 1764g03.p1k High (23-24) moderate
53 T. congolense TcoMSP-E not probable not probable
54 T. brucei TREU927 XM 823843 not probable not probable
55 T.b. gambiense 11 v2-orf1 not probable low
∗See supplementary data for full protein sequences.
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Figure 4: Multiple sequence alignment of MSP putative functional homologues: and T. congolense TcoMSP-D, T. brucei TREU927
XM 823726, T. gambiense chromosome 11 MSP ORF3. The predicted amino acid sequences for each homologue were aligned using the
ClustalW alignment tool. Output was directly generated using ClustalX for Windows. The dashed red box indicates a conserved motif
shown to be essential for Zn2+ binding in related proteins.
3.4. Eﬀect of TcoMSP-D Immunization on Infection by T.
congolense. We wished to address whether prior immu-
nization of mice with recombinant TcoMSP-D amino-
terminal domain provides protection against a T. congolense
infection. BALB/c mice were immunized with puriﬁed
protein in adjuvant and sera were collected at various times
post immunization. Figure 6(a) shows that immunization
generated a strong IgG1 antibody response to TcoMSP-
D amino-terminal domain as measured by ELISA. There
was also a detectable but modest IgG2a antibody response
(Figure 6(b)).Whenwechallengedtheimmunizedmicewith
ad oseof10 4 T. congolense TC14orhigher,allcontrolmiceas
well as all mice immunized with the amino-terminal domain
of TcoMSP-D developed parasitemia (data not shown).
Thus, at high-dose challenge the immunization had no
observable eﬀect.
To determine if immunized mice had gained increased
protection to a lower dose challenge, we challenged immu-
nized and control (adjuvant only) BALB/c mice with a
subcutaneous low-dose infection in the hind footpad. This
route and challenge size was chosen as it provides a border
line infection probability. The results of a typical challenge
assay are shown in Figure 7. BALB/c mice that had received
adjuvant only and were infected with 2 × 103 T. congolense
clone TC14 did not develop parasitemia (Figure 7(a))a n d
remained entirely healthy until the end of the observation
period of 30 days (Figure 7(d)). More than 50% of the mice
immunized with either 5μgo r5 0μg of the amino-terminal
domain of TcoMSP-D, however, developed parasitemia
(Figures 7(b) and 7(c))a n dh a dam e a n5 0 %s u r v i v a lt i m e
of only 11 days (Figure 7(d)). Thus unexpectedly, immu-
nization with TcoMSP-D amino-terminal domain results in10 Journal of Biomedicine and Biotechnology
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Figure 5 :D e m o n s t r a t i o no fT c o M S P - Di nw h o l ec e l ll y s a t e so fT.
congolense and in cell-free serum of infected mice. Cell-free serum
(equivalent to 0.2μL of undiluted serum) from control and infected
mice and T. congolense whole cell lysates were separated by SDS
PAGEandtransferredtonylonmembraneforWesternanalysis.The
membrane was probed with rabbit α-TcoMSP-D (NH3 domain) at
1/500 dilution and visualized with goat α-rabbit HRP conjugated
secondary antibody at 1/500 dilution. Lane 1: molecular weight
standards; lane 2: normal mouse serum; lane 3: serum from T.
congolense-infected mouse at 3 days post infection; lane 4: empty
l a n e ;l a n e5 :s e r u mf r o mT. congolense-infected mouse at 6 days post
infection; lane 6: lysate from equivalent of 5 million blood-form T.
congolense parasites; lane 7: molecular weight standards.
a signiﬁcant increase in susceptibility to infection with T.
congolense.
4. Discussion
Kinetoplastid protozoa have been known to encode a
conserved family of zinc metalloproteases on their surface,
collectively called Major Surface Proteases (MSPs) [7, 9].
In vitro treatment of T. brucei with a peptidomimetic
inhibitor, which has been demonstrated to inhibit a puriﬁed
predominant L. major MSP in vitro, also results in active
killing of T. brucei [8]. This ﬁnding strongly suggests that at
least one MSP protein in T. brucei plays a vital role in cell
survival. To date, there has not been any report of a member
of this family of proteins in T. congolense. Given the expected
conservation of this family of potentially surface-exposed
proteins in T. congolense, and the potential for targeting
this group of proteins as invariant surface antigens and key
virulence factors, we have searched for potential homologues
predicted to be encoded within the partially completed
T. congolense genomic DNA sequence. We were successful
in identifying six potential homologues. The large degree
of variation among all but two of the predicted proteins
suggested to us that these homologues were likely to have
diﬀering roles in the T. congolense life cycle. To date, three
subtypesofMSPshavebeendescribedintherelatedT. brucei.
ThesehavebeennamedTbMSP-A,TbMSP-B,andTbMSP-C
[7]. Of these only TbMSP-B has been characterized to a level
wherebyitsexpressionpatternandtargetsubstratehavebeen
demonstrated,indicatingthatthereisstillverymuchtolearn
about the roles these proteins play in trypanosome biology
[7, 19]. As a starting point to understanding the observed
divergence among the T. congolense MSPs we performed a
phylogenic analysis including the closest homologues from
related trypanosomes and Leishmania sp. Our ﬁnding of
ﬁve conserved subfamilies among the African trypanosomes
clearly indicates that we have identiﬁed diverse, conserved
functional subfamilies within the MSP family of proteins.
Not surprisingly, the TbMSP-A, -B, -C proteins each fall in a
separate subfamily. In addition, we have identiﬁed two novel
subfamilies which we have named MSP-D and MSP-E. We
believe this to be a major ﬁnding. However it is important to
stress that, as was the case for the initial report of T. brucei
MSP subfamilies [7], additional subfamilies may become
apparent as additional complete genomic sequences become
available.Indeed,T. congolense maylikelybeshowntoharbor
additional MSPs that have yet to be sequenced.
Notably,thelessrelatedNewWorldtrypanosomeT.cruzi
has members in the MSP-D (proteins 1 and 2 in Figure 3
and Table 1) and MSP-C (proteins 15–18 in Figure 3 and
Table 1) subfamilies as well as a grouping of six related
proteins in what appears to be their own subfamily that
maps near the MSP-B subfamily (Figure 3). This may suggest
that the MSP-D and MSP-C subfamilies are more ancient
than,forexample,theMSP-Asubfamily,oralternatively,that
this subfamily was lost in the T. cruzi species after species
separation. As a consequence, the MSP-A subfamily may be
uniquely required for an aspect of the African trypanosome
life cycle that is not shared with T. cruzi. Similarly, even
though the protein homologues most similar to each indi-
vidual T. congolense MSP were independently obtained from
the database, the entirety of unique Leishmania homologues
groups together in the phylogenic tree. This indicates that
each is more similar to other Leishmania proteins than to
any Trypanosome protein included in the analysis. This may
indicate separation of Leishmania from trypanosomes prior
to the generation of the subfamilies or species-speciﬁc loss of
all but one of the subfamilies in Leishmania species. Notably,
Leishmania MSPs have recently been shown to fall into three
distinct clades as well [24]. It may be of interest to determine
ifthehomologuesretrievedherearerestrictedtoonecladeor
represent multiple clades. Of particular interest is the ﬁnding
that the Leishmania MSP subfamily branches out closest to
the MSP-D subfamily, which, as argued above, may be one of
the more ancient subfamilies.
To test the potential usefulness of immunization against
members of a given MSP subfamily, we chose to con-
centrate on TcoMSP-D. This member had a number of
perceived characteristics that attracted our attention. The
MSP-D subfamily falls in a node that is closest to the
MSPs of Leishmania.ALeishmania MSP, called GP63 or
leishmanolysin, is an important virulence factor that has
been demonstrated, among other functions, to protect L.
major against complement-mediated lysis [25]. GP63 can
cleave complement component C3 and in particular cleave
C3b into iC3b [25], which, in turn, prevents complement-
mediated lysis of L. major but favors its CR3-mediated
phagocytosis by macrophages [25].Journal of Biomedicine and Biotechnology 11
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Figure 6: Immunization with a high dose (50μg/mouse) of TcoMSP-D resulting in an increased antigen speciﬁc IgG1 antibody response.
Groups of 5 BALB/c mice were immunized subcutaneously with TiterMax alone (Control), 5μg, or 50μg of antigen TcoMSP-D (amino-
terminal domain) in TiterMax at 4 diﬀerent sites (25μL/site). Serum was collected at weeks 2, 4, and 6 postimmunization. Sera IgG1 (a) and
IgG2a (b) speciﬁc for TcoMSP-D were determined by ELISA. The 50μg group showed a signiﬁcantly higher IgG1 antibody titer than the
control group at week 4 and week 6 postimmunization. ∗P ≤ .05; ∗∗P ≤ .005.
T. congolense infections lead to profound and persistent
hypocomplementia in cattle [26], sheep [27], and mice [28].
Homogenates of T. congolense, and particulate as well as
supernatant fractions thereof, activate bovine complement
via the alternative pathway [10]. Binding of IgM antibodies
to the variant surface glycoprotein of T. congolense activates
complement, mediates binding of C3b to the trypanosomes,
and leads to phagocytosis of T. congolense by macrophages
via complement receptor 3 (CR3) [29]. Lysis of T. congolense
by antibody and complement is ineﬃcient [30, 31]. Since
we found that TcoMSP-D appears to be most closely related
to Leishmania GP63 (Figure 3), we are considering that
TcoMSP-D may have enzyme activities similar to those
of Leishmania GP63. Our demonstration that TcoMSP-D
accumulates in mouse serum to greater than 50-fold higher
levels than can be accounted for by intact live trypanosomes
by day 6 post infection (Figure 5) is consistent with an
extracellular role. It is intriguing to speculate that the
ineﬃciency of complement-mediated lysis of T. congolense
might be mediated by the eﬀects of TcoMSP-D. Deﬁnitive
testing of this hypothesis will require puriﬁcation of the
active form of the protein.
Our ﬁnding that immunization against TcoMSP-D
amino-terminal domain signiﬁcantly enhanced the infectiv-
ity of a low dose of T. congolense was unanticipated. We
expected that the binding of the antibody to the MSP would
inhibit the function of this MSP and either would lead to an
attenuated infection, or would have no detectable eﬀect. The
demonstration of an eﬀect of enhanced infectivity (Figure 7)
indicates that immune responses against this MSP protein
cansomehowdownregulatetheresistancetoinfection.CD4+
CD25+ Foxp3+ T regulatory cells are involved in immune
suppression in T. congolense infections [32]. When mice
were infected subcutaneously with a low dose of T. con-
golense clone TC13 (102), they controlled the infection but
showed enhanced susceptibility upon subcutaneous chal-
lenge with a diﬀerent clone of T. congolense (Wei and Tabel,
unpublished). Though this ﬁnding very closely mirrors
the increased susceptibility seen in TcoMSP-D immunized
mice, we presently have no information on the potential
mechanism(s) responsible. Perhaps signiﬁcantly, the amino-
terminal domain of TcoMSP-D, used for immunization, did
not include the potential catalytic site (Figure 1). How could
one envision an increase of infectivity of T. congolense by
a speciﬁc antibody response to the N-terminal fragment
of the putative enzyme? It is conceivable that, rather than
neutralizing enzyme activity, the binding of antibodies
to the N-terminal portion of the putative enzyme might
actually stimulate its activity, as has been demonstrated
for antibody binding to horse radish preoxidase [33]. The
propeptide of Leishmania GP63 inhibits the activation of
the proenzyme [34]. It is conceivable that the antibody,
when binding to the N-terminal domain of the putative
proenzyme form of TcoMSP-D, might alter the structure of
the protein in such a way that it is able to exert enzyme
activity.
In summary, we have cloned, expressed, and puriﬁed
a partial protein encoding the amino-terminal domain of
TcoMSP-D, the T. congolense MSP homologue found to
be most closely related to Leishmania GP63. Whatever12 Journal of Biomedicine and Biotechnology
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Figure 7: Immunization with TcoMSP-D amino-terminal domain resulted in increased susceptibility to infection: enhanced parasitemia
and shorter survival time. Groups of 5 BALB/c mice were injected subcutaneously (s.c.) with TiterMax alone (Control), 5μg, or 50μgo ft h e
amino-terminal domain of TcoMSP-D in TiterMax at 4 diﬀerent sites (25μL/site). Six weeks postimmunization, all mice were infected with
2 × 103 T. congolense clone TC14 s.c. in a hind footpad. Parasitemia of the individual mice in each group [(a), control; (b), 5 μg; (c), 50 μg]
and survival (d) were monitored after the infection. Mice which did not show any detectable parasitemia lived normally without any sign of
disease until the termination of the experiment on day 30 postinfection. The results are representative of two diﬀerent experiments.
the mechanism might be, our observations have led us
to conclude that TcoMSP-D is a virulence factor of T.
congolense.
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